Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
60.00
0.45 (0.76%)
BSENSE

Dec 05

BSE+NSE Vol: 186

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "60.00",
    "chg": 0.45,
    "chgp": "0.76%",
    "dir": 1,
    "prev_price": "59.55",
    "mcapval": "220.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE102E01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "186 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Oxygenta Pharma’s Evaluation Revised Amidst Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3744024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/OxygentaPharma_mojoScore_3744024.png",
        "date": "2025-12-03 11:08:14",
        "description": "Oxygenta Pharma has experienced a revision in its market evaluation, reflecting shifts in its financial performance and market positioning. This adjustment highlights ongoing challenges within the Pharmaceuticals & Biotechnology sector, particularly for microcap companies facing operational and valuation pressures."
      },
      {
        "title": "Oxygenta Pharmaceutical Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-hits-upper-circuit-amidst-unprecedented-buying-interest-3720527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3720527.png",
        "date": "2025-11-21 10:10:38",
        "description": "Oxygenta Pharmaceutical has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong demand despite recent price pressures and sector trends."
      },
      {
        "title": "Why is Oxygenta Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-oxygenta-pharma-fallingrising-3719348",
        "imagepath": "",
        "date": "2025-11-21 00:49:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Oxygenta Pharma’s share price has been on a downward trajectory over the past week, falling by 3.07%, in stark contrast to the Sensex’s gain of 1.37% during the same period. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Over the last month, the stock has declined by 6.44%, while the Sensex has advanced by 1.50%, further emphasising the stock’s underperformance.</p>\n<p>Year-to-date figures paint a more concerning picture, with Oxygenta Pharma down 32.43%, whereas the Sensex has risen by 9.59%. Even over the last year, the stock has lost 22.75%, while the benchmark index gained 10.38%. These figures suggest that despite some longer-term gains over three and five years, the recen..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Surges 5% Today, Reaching Intraday High of Rs 63.87",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-5-today-reaching-intraday-high-of-rs-6387-3706847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3706847.png",
        "date": "2025-11-17 10:20:39",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing notable buying activity, with a significant stock increase today, reversing a two-day decline. Despite recent challenges, the stock has shown impressive long-term growth over five years. Current performance metrics indicate mixed technical signals, reflecting ongoing market sentiment and potential sector developments."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Surges 4.99% Today, Reaching Intraday High of Rs 63.99",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-surges-499-today-reaching-intraday-high-of-rs-6399-3701019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_buyers_3701019.png",
        "date": "2025-11-14 10:00:36",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing notable buying activity, with the stock rising significantly today, in contrast to a decline in the Sensex. Despite recent challenges, the stock has shown resilience over the past month, outperforming the index, while current trading indicates mixed trends in the short to medium term."
      },
      {
        "title": "Why is Oxygenta Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-oxygenta-pharma-fallingrising-3687134",
        "imagepath": "",
        "date": "2025-11-10 23:00:10",
        "description": "As of 10-Nov, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 62.40, which reflects a decrease of Rs 2.07 or 3.21%. The stock has been underperforming, having lost 6.64% over the last two days and is currently trading below its recent moving averages, specifically lower than the 5-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has underperformed its sector by 4.26% today. In terms of returns, over the past week, the stock has decreased by 3.81%, while it has shown a significant decline of 28.66% year-to-date and 29.76% over the past year, despite a strong performance over the last three and five years.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has only decreased by 0.53% over the past week, Oxygenta's short-term performance is notably weaker. The Sensex has shown a positive return of 1.25% over the past month, ..."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Faces Significant Selling Pressure with 35.03% Decline Over Three Months",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-faces-significant-selling-pressure-with-3503-decline-over-three-months-3684736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/OxygentaPharmac_only_sellers_3684736.png",
        "date": "2025-11-10 09:31:43",
        "description": "Oxygenta Pharmaceutical Ltd is experiencing significant selling pressure, with consecutive losses leading to an 8.29% decline over two days. The stock has underperformed against the Sensex, showing a 35.03% drop over the past three months and trading below key moving averages, indicating ongoing challenges in the market."
      },
      {
        "title": "How has been the historical performance of Oxygenta Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-oxygenta-pharma-3683561",
        "imagepath": "",
        "date": "2025-11-09 22:42:18",
        "description": "Answer:\nThe historical performance of Oxygenta Pharma shows significant fluctuations in its financial metrics over the years, with a notable increase in net sales in March 2025 reaching 109.30 Cr, up from 39.64 Cr in March 2024 and 30.99 Cr in March 2023. However, the company has faced challenges with total expenditure, which rose to 119.30 Cr in March 2025 from 49.34 Cr in March 2024, leading to an operating profit of -10.00 Cr in March 2025, slightly worse than -9.70 Cr in the previous year. The profit before tax also declined to -14.35 Cr in March 2025 from -13.87 Cr in March 2024, while the profit after tax was -10.30 Cr, worsening from -3.48 Cr in March 2024. The company's total liabilities increased to 72.62 Cr in March 2025 from 54.46 Cr in March 2024, with total debt at 62.23 Cr. Shareholder's funds remained negative at -25.02 Cr in March 2025, indicating ongoing financial distress. Cash flow from o..."
      },
      {
        "title": "Are Oxygenta Pharma latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-oxygenta-pharma-latest-results-good-or-bad-3682456",
        "imagepath": "",
        "date": "2025-11-08 19:20:17",
        "description": "Oxygenta Pharmaceutical's latest financial results for Q2 FY26 reflect significant operational challenges and a deteriorating financial position. The company reported a net loss of ₹6.11 crores, which represents a substantial decline compared to the previous quarter's performance. Revenue for the quarter was ₹15.13 crores, indicating a drastic quarter-on-quarter decline of 69.42%, despite a modest year-on-year growth of 19.89%. This volatility in revenue generation raises concerns about the sustainability of its business model.\n\nThe operating margin, which fell to -45.14%, marks the worst performance in at least seven quarters, highlighting severe structural issues within the company's cost management and operational execution. Additionally, the profit after tax (PAT) margin deteriorated to -40.38%, reflecting the ongoing struggles to achieve profitability amid rising operational losses.\n\nOn a broader scale..."
      }
    ],
    "total": 206,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "12-Nov-2025",
      "details": "Submission of Newspaper Publications",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Calendar Of Events For The Postal Ballot Process Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "11-Nov-2025",
      "details": "Calendar of Events of Postal Ballot",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "11-Nov-2025",
      "details": "Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclsoure Requirements) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Oxygenta Pharma falling/rising?

2025-11-21 00:49:21

Recent Price Movement and Market Comparison

Oxygenta Pharma’s share price has been on a downward trajectory over the past week, falling by 3.07%, in stark contrast to the Sensex’s gain of 1.37% during the same period. This divergence highlights the stock’s relative weakness amid a generally positive market environment. Over the last month, the stock has declined by 6.44%, while the Sensex has advanced by 1.50%, further emphasising the stock’s underperformance.

Year-to-date figures paint a more concerning picture, with Oxygenta Pharma down 32.43%, whereas the Sensex has risen by 9.59%. Even over the last year, the stock has lost 22.75%, while the benchmark index gained 10.38%. These figures suggest that despite some longer-term gains over three and five years, the recen...

Read More
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

12-Nov-2025 | Source : BSE

Submission of Newspaper Publications

Intimation Of Calendar Of Events For The Postal Ballot Process Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

11-Nov-2025 | Source : BSE

Calendar of Events of Postal Ballot

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

11-Nov-2025 | Source : BSE

Notice of Postal Ballot - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclsoure Requirements) Regulations 2015.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available